Paul Little

Insider Reports History

Location
Santa Barbara, CA
Signature
/s/ Paul Little
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paul Little:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. Chief Financial Officer Stock Option (right to buy) 175,000 $813,800 $1.55 10 Jan 2025 Direct
Eledon Pharmaceuticals, Inc. Chief Financial Officer Restricted Stock Units 75,000 10 Jan 2025 Direct

Insider Reports Filed by Paul Little

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELDN Eledon Pharmaceuticals, Inc. 10 Jan 2025 2 $0 4 Chief Financial Officer 13 Jan 2025, 17:30
ELDN Eledon Pharmaceuticals, Inc. 21 Nov 2024 1 $0 4 Chief Financial Officer 22 Nov 2024, 17:00
ELDN Eledon Pharmaceuticals, Inc. 13 Jun 2024 1 $0 4 Chief Financial Officer 14 Jun 2024, 17:00
ELDN Eledon Pharmaceuticals, Inc. 01 May 2023 1 $0 4 Chief Financial Officer 02 May 2023, 18:47
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 Chief Financial Officer 02 Feb 2023, 16:40
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 Chief Financial Officer 02 Feb 2022, 16:23
ELDN Eledon Pharmaceuticals, Inc. 11 Jun 2021 1 +$88,700 4 CHIEF FINANCIAL OFFICER 14 Jun 2021, 17:24